Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Infliximab

Infliximab Reactions 1704, p199 - 2 Jun 2018 Drug hypersensitivity reactions and infections: 4 case reports In a study of 12 patients from the STAT registry, four patients (three women and one man), aged 43–60 years, were described. A woman developed a drug-hypersensitivity reaction during treatment with infliximab. The remaining three patients developed infections during treatment with infliximab [doses, durations of treatment to reactions onsets and outcomes not stated]. A 49-year-old woman (Patient 7), who was diagnosed with neurosarcoidosis with severe localisation, also had upper respiratory tract involvement presenting with crusting. She had received treatment with unspecified corticosteroids and immunosuppressants initially. She started receiving treatment with IV infliximab infusion. She was scheduled to receive the infliximab infusions at weeks 0, 2 and 6 followed by every 4–8 weeks. She also received an unspecified immunosuppressant concomitantly. Subsequently, she developed an infection due to the infliximab treatment. Her infliximab therapy was then discontinued permanently. A 43-year-old man (Patient 8), who was diagnosed with neurosarcoidosis with severe localisation, also had upper respiratory tract involvement presenting with nasal obstruction. He had received treatment with unspecified corticosteroids and immunosuppressants initially. He started receiving treatment with IV infliximab infusion. He was scheduled to receive the infliximab http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Infliximab

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018

Infliximab

Abstract

Reactions 1704, p199 - 2 Jun 2018 Drug hypersensitivity reactions and infections: 4 case reports In a study of 12 patients from the STAT registry, four patients (three women and one man), aged 43–60 years, were described. A woman developed a drug-hypersensitivity reaction during treatment with infliximab. The remaining three patients developed infections during treatment with infliximab [doses, durations of treatment to reactions onsets and outcomes not stated]. A 49-year-old woman...
Loading next page...
1
 
/lp/springer_journal/infliximab-Tjpk1QCNr5

References (1)

Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
DOI
10.1007/s40278-018-46842-4
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p199 - 2 Jun 2018 Drug hypersensitivity reactions and infections: 4 case reports In a study of 12 patients from the STAT registry, four patients (three women and one man), aged 43–60 years, were described. A woman developed a drug-hypersensitivity reaction during treatment with infliximab. The remaining three patients developed infections during treatment with infliximab [doses, durations of treatment to reactions onsets and outcomes not stated]. A 49-year-old woman (Patient 7), who was diagnosed with neurosarcoidosis with severe localisation, also had upper respiratory tract involvement presenting with crusting. She had received treatment with unspecified corticosteroids and immunosuppressants initially. She started receiving treatment with IV infliximab infusion. She was scheduled to receive the infliximab infusions at weeks 0, 2 and 6 followed by every 4–8 weeks. She also received an unspecified immunosuppressant concomitantly. Subsequently, she developed an infection due to the infliximab treatment. Her infliximab therapy was then discontinued permanently. A 43-year-old man (Patient 8), who was diagnosed with neurosarcoidosis with severe localisation, also had upper respiratory tract involvement presenting with nasal obstruction. He had received treatment with unspecified corticosteroids and immunosuppressants initially. He started receiving treatment with IV infliximab infusion. He was scheduled to receive the infliximab

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

There are no references for this article.